Chetna Dureja

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

High Fat Diet Induced

Methicillin Resistant Staphylococcus Aureus

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Chetna Dureja, Jacob T Rutherford, Fahad B A Pavel, Krissada Norseeda, Isaac Prah, Dianqing Sun, Kirk E Hevener, Julian G Hurdle
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrobial agents and chemotherapy 68 (3) (2024)